William Guyer's Transactions in Corcept Therapeutics Inc.

William Guyer, Chief Development Officer of Corcept Therapeutics Inc., reported several transactions involving the company's common stock and stock options. On August 5, 2025, Guyer exercised stock options to acquire 14 shares of common stock at a price of $0.00 per share, with an exercise price of $21.65. Additionally, he sold 14 shares of common stock at $71.77 per share, also on August 5, 2025. These transactions were made pursuant to a 10b5-1 plan adopted by Guyer on November 27, 2024. Following these transactions, Guyer owns 385,007 shares of common stock directly and 5,487 shares indirectly. The transactions were reported in a Form 4 filing with the SEC.